Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,747 | 58,131 | 69,046 | 66,105 | 74,593 |
| TOTAL | $47,918 | $60,886 | $70,073 | $67,351 | $75,917 |
| Non-Current Assets | |||||
| PPE Net | 4,503 | 4,706 | 3,853 | 3,168 | 2,165 |
| Other Non-Current Assets | 2,446 | 2,170 | 2,406 | 2,398 | 2,748 |
| TOTAL | $6,949 | $6,876 | $6,259 | $5,566 | $4,913 |
| Total Assets | $54,867 | $67,762 | $76,332 | $72,917 | $80,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,125 | 2,912 | 1,899 | 1,169 | 922 |
| Accrued Expenses | 4,258 | 3,968 | 2,976 | 1,994 | 2,977 |
| TOTAL | $18,246 | $17,773 | $5,904 | $4,170 | $4,884 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,789 | 9,841 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 379 | 656 | 929 | 1,196 | 1,454 |
| TOTAL | $2,305 | $2,801 | $12,929 | $1,196 | $1,454 |
| Total Liabilities | $20,551 | $20,574 | $18,833 | $5,366 | $6,338 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 260 | 260 | 260 | 260 | 259 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -193,397 | -179,780 | -168,725 | -157,686 | -149,884 |
| TOTAL | $34,316 | $47,188 | $57,499 | $67,551 | $74,492 |
| Total Liabilities And Equity | $54,867 | $67,762 | $76,332 | $72,917 | $80,830 |